Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Li-Yue
NCT06472908: Efficacy and Safety of Colchicine After PCI	Not yet recruiting	3	8862	RoW	Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo	Wuhan Union Hospital, China	Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine	03/28	08/28